담관암종에서 혈청반응인자의 발현과 예후 인자로서의 의의
Expression and Prognostic Significance of Serum Response Factor in Cholangiocarcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Serum response factor (SRF) is a transcriptional factor that plays an important role in cell growth and differentiation for several types of cells. The expression of SRF in cholangiocarcinoma (CC) and its potential role has not been examined. The aim of this study was to determine the relationship between the expression of SRF in CC and the clinicopathological parameters, as well as patient survival. Methods : We analyzed the expression of SRF in 84 surgically resected cases of CC (33 cases of intrahepatic CC [ICC] and 51 cases of extrahepatic CC [ECC]) by using immunohistochemistry. Results : The positive expression of SRF was detected in 48.8% of the cases of CC (42.4% in ICC, 52.9% in ECC). SRF was predominantly expressed in the CC cells with intense labeling in the nucleus. A SRF expression was significantly associated with the cell proliferation rate (Ki-67 labeling index, p=0.046) and poor patient survival (p=0.002). The tumor differentiation (p=0.038), the T category (p<0.001), lymph node and distant metastasis (p<0.001, p=0.009) and nerve and vessel invasion (p=0.010, p=0.012) were also found to be significantly associated with a poor CC prognosis. Conclusions : These results suggest that the SRF may play a role in the tumor cell proliferation of CC, and its expression in tumor cells can provide additional prognostic information.
Abstract
Background : Serum response factor (SRF) is a transcriptional factor that plays an important role in cell growth and differentiation for several types of cells. The expression of SRF in cholangiocarcinoma (CC) and its potential role has not been examined. The aim of this study was to determine the relationship between the expression of SRF in CC and the clinicopathological parameters, as well as patient survival. Methods : We analyzed the expression of SRF in 84 surgically resected cases of CC (33 cases of intrahepatic CC [ICC] and 51 cases of extrahepatic CC [ECC]) by using immunohistochemistry. Results : The positive expression of SRF was detected in 48.8% of the cases of CC (42.4% in ICC, 52.9% in ECC). SRF was predominantly expressed in the CC cells with intense labeling in the nucleus. A SRF expression was significantly associated with the cell proliferation rate (Ki-67 labeling index, p=0.046) and poor patient survival (p=0.002). The tumor differentiation (p=0.038), the T category (p<0.001), lymph node and distant metastasis (p<0.001, p=0.009) and nerve and vessel invasion (p=0.010, p=0.012) were also found to be significantly associated with a poor CC prognosis. Conclusions : These results suggest that the SRF may play a role in the tumor cell proliferation of CC, and its expression in tumor cells can provide additional prognostic information.
참고문헌 (27)
- Esposito I, "Pathological aspects of cholangiocarcinoma", HPB, 10, pp.83~86 (2008)
- Shore P, "The MADS-box family of transcription factors", Eur J Biochem, 229, pp.1~13 (1995)
- Treisman R, "Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′element and c-fos 3′sequences", Cell, 42, pp.889~902 (1985)
- Gilman MZ, "Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression", Mol Cell Biol, 6, pp.4305~4316 (1986)
- Treisman R, "Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors", Cell, 46, pp.567~574 (1986)
- Norman C, "Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element", Cell, 55, pp.989~1003 (1988)
- Chai J, "Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing", J Physiol Pharmacol, 53, pp.147~157 (2002)
- Schratt G, "Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells", Mol Cell Biol, 21, pp.2933~2943 (2001)
- Camoretti-Mercado B, "Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor", J Biol Chem, 275, pp.30387~30393 (2000)
- Ding W, "Senescence represses the nuclear localization of the serum response factor and differentiation regulates its nuclear localization with lineage specificity", J Cell Sci, 114, pp.1011~1018 (2001)
- Bertolotto C, "Cleavage of the serum response factor during death receptor-induced apoptosis results in an inhibition of the c-FOS promoter transcriptional activity", J Biol Chem, 275, pp.12941~12947 (2000)
- Zhang X, "Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor", J Biol Chem, 276, pp.40033~40040 (2001)
- Alberti S, "Neuronal migration in the murine rostral migratory stream requires serum response factor", Proc Natl Acad Sci, pp.6148~6153 (2005)
- Charvet C, "New role for serum response factor in postnatal skeletal muscle growth and regeneration via the interleukin 4 and insulin-like growth factor 1 pathways", Mol Cell Biol, 26, pp.6664~6674 (2006)
- Patten LC, "Serum response factor is alternatively spliced in human colon cancer", J Surg Res, 121, pp.92~100 (2004)
- Park MY, "Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition", Int J Oncol, 31, pp.1309~1315 (2007)
- Choi HN, "Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin", beta-catenin complex, 2009, pp.21, 57~63
- Song XC, "Protein expression profiling of breast cancer cells by dissociable antibody microarray (DAMA) staining", Mol Cell Proteomics, 7, pp.163~169 (2008)
- Gavert N, "Epithelial-mesenchymal transition and the invasive potential of tumors", Trends Mol Med, 14, pp.199~209 (2008)
- Mejlvang J, "Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition", Exp Cell Res, 313, pp.380~393 (2007)
- Chai J, "Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis", FASEB J, 18, pp.1264~1266 (2004)
- Lee HJ, "SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling", Oncogene, 26, pp.173~185 (2007)
- Schratt G, "SRF regulates Bcl-2 expression and promotes cell survival during murine embryonic development", EMBO J, 23, pp.1834~1844 (2004)
- Gerdes J, "Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67", J Immunol, 133, pp.1710~1715 (1984)
- Sun K, "Hepatocyte expression of serum response factor is essential for liver function, hepatocyte proliferation and survival, and postnatal body growth in mice", Hepatology, 49, pp.1645~1654 (2009)
- Zhang X, "Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor", Am J Physiol Heart Circ Physiol, 280, pp.H1782~H1792 (2001)
- Heemers HV, "Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer", Cancer Res, 67, pp.10592~10599 (2007)